Geneva, Switzerland and Boston, MA – August 30, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical…
Month: August 2019
ObsEva SA to present at Wedbush PacGrow Healthcare Conference – click ‘Read More’ below for webcast info
Click here for webcast Date & Time: Wednesday 14 August 2019 @ 10:55 a.m. ET / 4:55 p.m CET Location: New…
Wedbush Presentation August 2019 in NYC
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 13- 14, 2019
Geneva, Switzerland and Boston, MA – August 9, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical…
Q2 2019 ObsEva SA Earnings Conference Call: Click ‘Read More’ Below for webcast info
Click here for webcast Date / Time07 Aug 2019 @ 8:00 a.m. ET / 2:00 p.m. CET
ObsEva SA Announces $75 Million Credit Facility with Oxford Finance LLC
Geneva, Switzerland and Boston, MA – August 7, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage…
ObsEva Reports Second Quarter 2019 Financial Results
Multiple Major Milestones Expected This Year Q4:19 Phase 3 data for IMPLANT 4 trial of nolasiban Nolasiban MAA…
Q2 Report 2019
ObsEva SA to Hold Second Quarter 2019 Financial Results and Business Update Call on August 7, 2019
Geneva, Switzerland and Boston, MA – August 5, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage…